ID   CDC7_HUMAN              Reviewed;         574 AA.
AC   O00311; D3DT31; O00558; Q5T5U5;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Cell division cycle 7-related protein kinase;
DE            Short=CDC7-related kinase;
DE            Short=HsCdc7;
DE            Short=huCdc7;
DE            EC=2.7.11.1;
GN   Name=CDC7; Synonyms=CDC7L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver, and Testis;
RX   PubMed=9250678; DOI=10.1093/emboj/16.14.4340;
RA   Sato N., Arai K., Masai H.;
RT   "Human and Xenopus cDNAs encoding budding yeast Cdc7-related kinases:
RT   in vitro phosphorylation of MCM subunits by a putative human homologue
RT   of Cdc7.";
RL   EMBO J. 16:4340-4351(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9573348; DOI=10.1016/S0378-1119(98)00094-8;
RA   Hess G.F., Drong R.F., Weiland K.L., Slightom J.L., Sclafani R.A.,
RA   Hollingsworth R.E.;
RT   "A human homolog of the yeast CDC7 gene is overexpressed in some
RT   tumors and transformed cell lines.";
RL   Gene 211:133-140(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RX   PubMed=9405610; DOI=10.1073/pnas.94.26.14320;
RA   Jiang W., Hunter T.;
RT   "Identification and characterization of a human protein kinase related
RT   to budding yeast Cdc7p.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14320-14325(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PRO-23; VAL-99;
RP   TRP-112; LEU-162 AND ARG-441.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH DBF4.
RX   PubMed=10373557; DOI=10.1128/MCB.19.7.5083;
RA   Kumagai H., Sato N., Yamada M., Mahony D., Seghezzi W., Lees E.,
RA   Arai K., Masai H.;
RT   "A novel growth- and cell cycle-regulated protein, ASK, activates
RT   human Cdc7-related kinase and is essential for G1/S transition in
RT   mammalian cells.";
RL   Mol. Cell. Biol. 19:5083-5095(1999).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH DBF4B.
RX   PubMed=12065429; DOI=10.1093/emboj/cdf290;
RA   Montagnoli A., Bosotti R., Villa F., Rialland M., Brotherton D.,
RA   Mercurio C., Berthelsen J., Santocanale C.;
RT   "Drf1, a novel regulatory subunit for human Cdc7 kinase.";
RL   EMBO J. 21:3171-3181(2002).
RN   [10]
RP   INTERACTION WITH DBF4B.
RX   PubMed=15668232; DOI=10.1074/jbc.M411653200;
RA   Yoshizawa-Sugata N., Ishii A., Taniyama C., Matsui E., Arai K.,
RA   Masai H.;
RT   "A second human Dbf4/ASK-related protein, Drf1/ASKL1, is required for
RT   efficient progression of S and M phases.";
RL   J. Biol. Chem. 280:13062-13070(2005).
RN   [11]
RP   INTERACTION WITH DBF4 AND DBF4B.
RX   PubMed=17062569; DOI=10.1074/jbc.M604457200;
RA   Tenca P., Brotherton D., Montagnoli A., Rainoldi S., Albanese C.,
RA   Santocanale C.;
RT   "Cdc7 is an active kinase in human cancer cells undergoing replication
RT   stress.";
RL   J. Biol. Chem. 282:208-215(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27 AND THR-503, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-162; MET-208; ASP-209; ARG-441;
RP   ILE-472 AND ALA-498.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Seems to phosphorylate critical substrates that regulate
CC       the G1/S phase transition and/or DNA replication. Can
CC       phosphorylates MCM2 and MCM3. {ECO:0000269|PubMed:12065429}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Forms a complex with either DBF4/DBF4A or DBF4B, leading
CC       to the activation of the kinase activity.
CC   -!- INTERACTION:
CC       Q9UBU7:DBF4; NbExp=3; IntAct=EBI-374980, EBI-372690;
CC       Q9BTE3:MCMBP; NbExp=2; IntAct=EBI-374980, EBI-749378;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms may be produced.;
CC       Name=1;
CC         IsoId=O00311-1; Sequence=Displayed;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. CDC7 subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdc7/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB003698; BAA19962.1; -; mRNA.
DR   EMBL; AF015592; AAC52080.1; -; mRNA.
DR   EMBL; AF005209; AAB97512.1; -; mRNA.
DR   EMBL; AY585721; AAS79323.1; -; Genomic_DNA.
DR   EMBL; AL355871; CAI14446.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW73114.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW73115.1; -; Genomic_DNA.
DR   EMBL; BC110526; AAI10527.1; -; mRNA.
DR   EMBL; BC110527; AAI10528.1; -; mRNA.
DR   EMBL; BC111044; AAI11045.1; -; mRNA.
DR   CCDS; CCDS734.1; -. [O00311-1]
DR   RefSeq; NP_001127891.1; NM_001134419.1. [O00311-1]
DR   RefSeq; NP_001127892.1; NM_001134420.1. [O00311-1]
DR   RefSeq; NP_003494.1; NM_003503.3. [O00311-1]
DR   RefSeq; XP_005271298.1; XM_005271241.2. [O00311-1]
DR   UniGene; Hs.533573; -.
DR   PDB; 4F99; X-ray; 2.33 A; A=37-574.
DR   PDB; 4F9A; X-ray; 2.17 A; A/C=37-574.
DR   PDB; 4F9B; X-ray; 2.50 A; A/C=37-574.
DR   PDB; 4F9C; X-ray; 2.08 A; A=37-574.
DR   PDB; 5UWR; X-ray; 2.24 A; D=456-478.
DR   PDBsum; 4F99; -.
DR   PDBsum; 4F9A; -.
DR   PDBsum; 4F9B; -.
DR   PDBsum; 4F9C; -.
DR   PDBsum; 5UWR; -.
DR   ProteinModelPortal; O00311; -.
DR   SMR; O00311; -.
DR   BioGrid; 113914; 34.
DR   DIP; DIP-31728N; -.
DR   IntAct; O00311; 42.
DR   MINT; MINT-1201209; -.
DR   STRING; 9606.ENSP00000234626; -.
DR   BindingDB; O00311; -.
DR   ChEMBL; CHEMBL5443; -.
DR   GuidetoPHARMACOLOGY; 1960; -.
DR   iPTMnet; O00311; -.
DR   PhosphoSitePlus; O00311; -.
DR   BioMuta; CDC7; -.
DR   EPD; O00311; -.
DR   MaxQB; O00311; -.
DR   PaxDb; O00311; -.
DR   PeptideAtlas; O00311; -.
DR   PRIDE; O00311; -.
DR   DNASU; 8317; -.
DR   Ensembl; ENST00000234626; ENSP00000234626; ENSG00000097046. [O00311-1]
DR   Ensembl; ENST00000428239; ENSP00000393139; ENSG00000097046. [O00311-1]
DR   GeneID; 8317; -.
DR   KEGG; hsa:8317; -.
DR   UCSC; uc001doe.4; human. [O00311-1]
DR   CTD; 8317; -.
DR   DisGeNET; 8317; -.
DR   GeneCards; CDC7; -.
DR   HGNC; HGNC:1745; CDC7.
DR   HPA; CAB002669; -.
DR   HPA; HPA035831; -.
DR   MIM; 603311; gene.
DR   neXtProt; NX_O00311; -.
DR   OpenTargets; ENSG00000097046; -.
DR   PharmGKB; PA26272; -.
DR   eggNOG; KOG1167; Eukaryota.
DR   eggNOG; ENOG410YKCM; LUCA.
DR   GeneTree; ENSGT00550000075011; -.
DR   HOGENOM; HOG000193450; -.
DR   HOVERGEN; HBG003991; -.
DR   InParanoid; O00311; -.
DR   KO; K02214; -.
DR   OMA; MAFSPQR; -.
DR   OrthoDB; EOG091G0O6H; -.
DR   PhylomeDB; O00311; -.
DR   TreeFam; TF101052; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-176187; Activation of ATR in response to replication stress.
DR   Reactome; R-HSA-68962; Activation of the pre-replicative complex.
DR   SignaLink; O00311; -.
DR   SIGNOR; O00311; -.
DR   GeneWiki; Cell_division_cycle_7-related_protein_kinase; -.
DR   GenomeRNAi; 8317; -.
DR   PRO; PR:O00311; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000097046; -.
DR   CleanEx; HS_CDC7; -.
DR   ExpressionAtlas; O00311; baseline and differential.
DR   Genevisible; O00311; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IDA:HGNC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IMP:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0044770; P:cell cycle phase transition; IMP:BHF-UCL.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006260; P:DNA replication; TAS:Reactome.
DR   GO; GO:0006270; P:DNA replication initiation; IBA:GO_Central.
DR   GO; GO:0000727; P:double-strand break repair via break-induced replication; IBA:GO_Central.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0006909; P:phagocytosis; IBA:GO_Central.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:HGNC.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0010571; P:positive regulation of nuclear cell cycle DNA replication; IMP:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle;
KW   Cell division; Complete proteome; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    574       Cell division cycle 7-related protein
FT                                kinase.
FT                                /FTId=PRO_0000085763.
FT   DOMAIN       58    574       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      64     72       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    177    177       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      90     90       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      27     27       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     503    503       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      23     23       Q -> P (in dbSNP:rs13447459).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019255.
FT   VARIANT      99     99       I -> V (in dbSNP:rs13447492).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019256.
FT   VARIANT     112    112       G -> W (in dbSNP:rs13447493).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019257.
FT   VARIANT     162    162       F -> L (in dbSNP:rs13447503).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019258.
FT   VARIANT     208    208       I -> M (in dbSNP:rs34979509).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040403.
FT   VARIANT     209    209       E -> D (in dbSNP:rs56327502).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040404.
FT   VARIANT     441    441       K -> R (in dbSNP:rs13447539).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_019259.
FT   VARIANT     472    472       T -> I (in dbSNP:rs56381770).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040405.
FT   VARIANT     498    498       S -> A (in dbSNP:rs35055915).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040406.
FT   CONFLICT     89     89       L -> V (in Ref. 3; AAB97512).
FT                                {ECO:0000305}.
FT   HELIX        42     50       {ECO:0000244|PDB:4F9C}.
FT   HELIX        52     56       {ECO:0000244|PDB:4F9C}.
FT   STRAND       59     66       {ECO:0000244|PDB:4F9C}.
FT   STRAND       68     79       {ECO:0000244|PDB:4F9C}.
FT   STRAND       84     92       {ECO:0000244|PDB:4F9C}.
FT   HELIX        98    110       {ECO:0000244|PDB:4F9C}.
FT   STRAND      121    126       {ECO:0000244|PDB:4F9C}.
FT   STRAND      129    135       {ECO:0000244|PDB:4F9C}.
FT   HELIX       142    146       {ECO:0000244|PDB:4F9C}.
FT   HELIX       151    170       {ECO:0000244|PDB:4F9C}.
FT   HELIX       180    182       {ECO:0000244|PDB:4F9C}.
FT   STRAND      183    186       {ECO:0000244|PDB:4F9C}.
FT   TURN        187    190       {ECO:0000244|PDB:4F9C}.
FT   STRAND      191    194       {ECO:0000244|PDB:4F9C}.
FT   HELIX       209    213       {ECO:0000244|PDB:4F9C}.
FT   TURN        217    219       {ECO:0000244|PDB:4F9A}.
FT   HELIX       377    379       {ECO:0000244|PDB:4F9C}.
FT   HELIX       382    385       {ECO:0000244|PDB:4F9C}.
FT   HELIX       394    409       {ECO:0000244|PDB:4F9C}.
FT   STRAND      412    415       {ECO:0000244|PDB:4F9C}.
FT   HELIX       420    431       {ECO:0000244|PDB:4F9C}.
FT   HELIX       433    442       {ECO:0000244|PDB:4F9C}.
FT   STRAND      445    451       {ECO:0000244|PDB:4F9C}.
FT   HELIX       458    465       {ECO:0000244|PDB:4F9C}.
FT   HELIX       540    549       {ECO:0000244|PDB:4F9C}.
FT   TURN        554    556       {ECO:0000244|PDB:4F9C}.
FT   HELIX       560    564       {ECO:0000244|PDB:4F9C}.
FT   HELIX       567    569       {ECO:0000244|PDB:4F9C}.
SQ   SEQUENCE   574 AA;  63888 MW;  90D549BEE20AE583 CRC64;
     MEASLGIQMD EPMAFSPQRD RFQAEGSLKK NEQNFKLAGV KKDIEKLYEA VPQLSNVFKI
     EDKIGEGTFS SVYLATAQLQ VGPEEKIALK HLIPTSHPIR IAAELQCLTV AGGQDNVMGV
     KYCFRKNDHV VIAMPYLEHE SFLDILNSLS FQEVREYMLN LFKALKRIHQ FGIVHRDVKP
     SNFLYNRRLK KYALVDFGLA QGTHDTKIEL LKFVQSEAQQ ERCSQNKSHI ITGNKIPLSG
     PVPKELDQQS TTKASVKRPY TNAQIQIKQG KDGKEGSVGL SVQRSVFGER NFNIHSSISH
     ESPAVKLMKQ SKTVDVLSRK LATKKKAIST KVMNSAVMRK TASSCPASLT CDCYATDKVC
     SICLSRRQQV APRAGTPGFR APEVLTKCPN QTTAIDMWSA GVIFLSLLSG RYPFYKASDD
     LTALAQIMTI RGSRETIQAA KTFGKSILCS KEVPAQDLRK LCERLRGMDS STPKLTSDIQ
     GHASHQPAIS EKTDHKASCL VQTPPGQYSG NSFKKGDSNS CEHCFDEYNT NLEGWNEVPD
     EAYDLLDKLL DLNPASRITA EEALLHPFFK DMSL
//
